Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Badovinac, M. Korsic, D. Capalija, B. Cucevic, L. Pavlovic, M. Roglic (Zagreb, Croatia). Is there a difference in response to first line chemotherapy related to age in patients with locally advanced or metastatic non-small lung cancer?. Eur Respir J 2013; 42: Suppl. 57, 4489

Member's Comments

No comment yet.

Related content which might interest you: Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC) Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Changes in lymphocyte subgroups of non-small cell lung cancer patients during chemotherapy Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy? Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Reduction of peak oxygen consumption in patients with non-small cell lung cancer treated with neoadjuvant chemotherapy Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Clinical outcome of S-1 monotherapy in patients with advanced non-small cell lung cancer after treatment of pemetrexed Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Adrenalectomy for isolated lesions in operable patients with non-small-cell lung cancer Source: International Congress 2016 – Special issues in thoracic surgery Year: 2016 Surgery for elderly early-stage non-small cell lung cancer: less or more? Source: International Congress 2019 – All aspects of general thoracic surgery Year: 2019 Pemetrexed in maintenance therapy of 164 patients with advanced non-small-cell lung cancer (NSCLC) Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 The prognostic significance of thrombocytopenia during chemotherapy in patients with advanced non-small cell lung cancer Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Should patients with metastatic NSCLC and poor performance status be treated by chemotherapy? Source: Annual Congress 2007 - Treatment of metastatic nonsmall cell lung cancer in the era of targeted therapies Year: 2007 Chemotherapy improves low performance status lung cancer patients Source: Eur Respir J 2007; 30: 1186-1192 Year: 2007 Multiple primary malignancies in Japanese patients with non-small cell lung cancer Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Surgical treatmment non-small cell lung cancer in the elderly patients Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Mortality in asymptomatic vs. symptomatic patients surgically treated for non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Major changes in men with non-small-cell lung cancer (NSCLC) in 10 years: The KBP-2000-CPHG and KBP-2010-CPHG cohorts Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Procalcitonin serum levels in patients with stage IV non-small cell lung cancer in first line of chemotherapy Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 Advanced non-small cell lung cancer in elderly patients Source: Breathe 2012; 9: 26-34 Year: 2012 Role of chemotherapy in stage III non-small cell lung cancer (NSCLC): adjuvant or induction? Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer Year: 2006 Outcomes of radical treatment of early stage non-small cell lung cancer Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015